Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 421

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation

Open access
Brouwer, Jorn, Nijenhuis, Vincent J., Delewi, Ronak, Hermanides, Renicus S., Holvoet, Wouter, Dubois, Christophe L.F., Frambach, Peter, De Bruyne, Bernard, van Houwelingen, Gert K., Van Der Heyden, Jan A.S., Toušek, Petr, van der Kley, Frank, Buysschaert, Ian, Schotborgh, Carl E., Ferdinande, Bert, van der Harst, Pim, Roosen, John, Peper, Joyce, Thielen, Frederick W.F., Veenstra, Leo, Chan Pin Yin, Dean R.P.P., Swaans, Martin J., Rensing, Benno J.W.M., van ’t Hof, Arnoud W.J., Timmers, Leo, Kelder, Johannes C., Stella, Pieter R., Baan, Jan, ten Berg, Jurriën M.·2020·New England Journal of Medicine

Abstract

BACKGROUND: The effect of single as compared with dual antiplatelet treatment on bleeding and thromboembolic events after transcatheter aortic-valve implantation (TAVI) in patients who do not have an indication for long-term anticoagulation has not been well studied. METHODS: In a randomized, controlled trial, we assigned a subgroup of patients who were undergoing TAVI and did not have an indication for long-term anticoagulation, in a 1:1 ratio, to receive aspirin alone or aspirin plus clopidogrel for 3 months. The two primary outcomes were all bleeding (including minor, major, and life-threatening or disabling bleeding) and non-procedure-related bleeding over a period of 12 months. Most bleeding at the TAVI puncture site was counted as non-procedure-related. The two secondary outcomes were a composite of death from cardiovascular causes, non-procedure-related bleeding, stroke, or myocardial infarction (secondary composite 1) and a composite of death from cardiovascular causes, ischemic stroke, or myocardial infarction (secondary composite 2) at 1 year, with both outcomes tested sequentially for noninferiority (noninferiority margin, 7.5 percentage points) and superiority. RESULTS: A total of 331 patients were assigned to receive aspirin alone and 334 were assigned to receive aspirin plus clopidogrel. A bleeding event occurred in 50 patients (15.1%) receiving aspirin alone and in 89 (26.6%) receiving aspirin plus clopidogrel (risk ratio, 0.57; 95% confidence interval [CI], 0.42 to 0.77; P = 0.001). Non-procedure-related bleeding occurred in 50 patients (15.1%) and 83 patients (24.9%), respectively (risk ratio, 0.61; 95% CI, 0.44 to 0.83; P = 0.005). A secondary composite 1 event occurred in 76 patients (23.0%) receiving aspirin alone and in 104 (31.1%) receiving aspirin plus clopidogrel (difference, -8.2 percentage points; 95% CI for noninferiority, -14.9 to -1.5; P<0.001; risk ratio, 0.74; 95% CI for superiority, 0.57 to 0.95; P = 0.04). A secondary composite 2 event occurred in 32 patients (9.7%) and 33 patients (9.9%), respectively (difference, -0.2 percentage points; 95% CI for noninferiority, -4.7 to 4.3; P = 0.004; risk ratio, 0.98; 95% CI for superiority, 0.62 to 1.55; P = 0.93). A total of 44 patients (13.3%) and 32 (9.6%), respectively, received oral anticoagulation during the trial. CONCLUSIONS: Among patients undergoing TAVI who did not have an indication for oral anticoagulation, the incidence of bleeding and the composite of bleeding or thromboembolic events at 1 year were significantly less frequent with aspirin than with aspirin plus clopidogrel administered for 3 months. (Funded by the Netherlands Organization for Health Research and Development; POPular TAVI EU Clinical Trials Register number, 2013-003125-28; ClinicalTrials.gov number, NCT02247128.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa2017815

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 421

Metadata

Authors
Brouwer, J., Nijenhuis, V. J., Delewi, R., Hermanides, R. S., Holvoet, W., Dubois, C. L. F., Frambach, P., De Bruyne, B., van Houwelingen, G. K., Van Der Heyden, J. A. S., Toušek, P., van der Kley, F., Buysschaert, I., Schotborgh, C. E., Ferdinande, B., van der Harst, P., Roosen, J., Peper, J., Thielen, F. W. F., Veenstra, L., Chan Pin Yin, D. R. P. P., Swaans, M. J., Rensing, B. J. W. M., van ’t Hof, A. W. J., Timmers, L., Kelder, J. C., Stella, P. R., Baan, J., & ten Berg, J. M.
Venue
New England Journal of Medicine
Published
2020-10-08
Volume
383
Issue
15
Pages
1447-1457
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W3082149041
Cited by
421
References
28
FWCI
33.10
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation. https://app.cochat.ai/papers/10.1056/nejmoa2017815
The paper
Brouwer, J., Nijenhuis, V. J., Delewi, R., Hermanides, R. S., Holvoet, W., Dubois, C. L. F., Frambach, P., De Bruyne, B., van Houwelingen, G. K., Van Der Heyden, J. A. S., Toušek, P., van der Kley, F., Buysschaert, I., Schotborgh, C. E., Ferdinande, B., van der Harst, P., Roosen, J., Peper, J., Thielen, F. W. F., . . . ten Berg, J. M. (2020). Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2017815

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.